Background: Because it directly affects the therapeutic effectiveness of poorly water soluble medications, bioavailability poses a serious barrier to pharmaceutical development. An efficient method for improving these medications' solubility and bioavailability is solid dispersion technology. Solid dispersions can increase the rate of dissolution and, in turn, the drug's absorption by dispersing the active pharmaceutical ingredient (API) in a carrier matrix.